The future is fermented: How Europe can succeed in the next industrial race

By Janka Oertel and Nina Schmelzer, European Council on Foreign Relations, 03 July 2026

The next industrial revolution will be built with microbes as much as machines. China understands this. Europe still has the science to compete but must act quickly before industrial leadership slips away again

Summary

- Biomanufacturing uses biological processes to produce food, fuels, chemicals and materials that today rely on fossil resources.

- The underlying science is not new. But advances in AI and falling renewable energy costs are transforming biomanufacturing from a niche climate solution into a new production paradigm, with the potential to reshape industrial competitiveness and geopolitical power much as fossil fuels did in the previous industrial age.

- China has identified biomanufacturing as a strategic technology for resilience and self-reliance, deploying a familiar playbook of state-backed investment and infrastructure to build globally competitive industries.

- Europe remains a formidable competitor, leading in patents and core technologies, with world-class research, specialised industrial clusters, skilled talent and globally competitive firms across the value chain.

- Its weaknesses are limited infrastructure, regulatory delays and growing dependence on Chinese manufacturing capacity.

- Without greater urgency, Europe risks repeating the mistakes it made in solar panels, batteries and electric vehicles: inventing breakthrough technologies while ceding profits and geopolitical leverage to China, this time with even greater consequences.

The microbe revolution

For two centuries, the molecules that underpin modern life have been pumped from the ground in the form of oil and gas. The next industrial revolution may instead grow them in laboratories and tanks.

This is the promise of biomanufacturing: using biological processes to produce the building blocks of the future economy. Scientists can programme living cells to act like microscopic factories, capable of producing everything from food, fuels and fertilisers to plastic, chemicals and advanced materials­—nearly all of which still rely to some degree on fossil resources. For millennia microbes were used to turn grain into beer and milk into cheese. Now they are engineered to turn straw into jet fuel and sugar into armour.

What sounds like science fiction is rapidly becoming reality. Driven by abundant and affordable renewable energy and dramatic advances in artificial intelligence (AI), biomanufacturing is beginning to change not only what economies produce, but how they produce it. In doing so, they address a deeper layer of fossil dependence than renewable electricity alone. The shift could be as transformative as the invention of the petrochemical industry itself. If the geographical distribution of fossil resources shaped the geopolitics of the last industrial age, then the ability to produce key molecules without them could shape the next.

China’s leaders have recognised this opportunity. Beijing has spent an average of roughly €1.4bn per year on electric vehicle research and development (R&D) over 15 years to build a globally dominant industry. It is now reportedly spending €2bn-3bn in biotechnology R&D alone. And it is doing this at a time when China already accounts for more than 70% of global basic fermentation capacity.

But its ambitions for the bioeconomy go much further. The 2022 Bioeconomy Five-Year Plan set a goal of global leadership by 2035, while the 2026 15th Five-Year Plan places biomanufacturing alongside AI at the heart of China’s future industrial model. In July 2025, Beijing unveiled a list of 35 flagship biomanufacturing products to replace fossil-based chemicals or food and feed additives, and selected 43 companies to build pilot plants. No other major power is investing in the bioeconomy with comparable scale or strategic intent.

But Europe has not lost the race to China just yet. As in areas like semi-conductors, European companies provide some of the key foundational technology and microbial strains that make Chinese fermentation successes possible. Europeans are at the cutting-edge of research—the continent has a thriving biosolutions sector worth €60bn, comparable to the GDP of Slovenia, and growing around 5% annually. And according to industry estimates, if scaled successfully, biomanufacturing could replace a quarter of European oil-based chemicals, halve the continent’s protein imports, drastically cut greenhouse gas emissions and create 700,000 additional jobs—by as soon as 2030.

Yet beneath these strengths lie familiar vulnerabilities. European firms already depend on Chinese producers for basic parts of the existing biomanufacturing value chain. As China scales its fermentation capacity, European start-ups are increasingly tempted to manufacture and scale there, exposing valuable intellectual property to a fierce competitor. In a 2025 report to Congress, the US-China Economic and Security Review Commission likened fermentation capacity to that of chip factories, warning that China’s dominance could become a strategic chokepoint. Policymakers are already losing sleep over China’s massive share of global rare-earth refining. But biomanufacturing could prove even more consequential. Imagine similar leverage extending across all future food, pharmaceuticals, chemicals and energy inputs.

Europe’s lack of urgency is worrying. Policymakers still seem to treat biomanufacturing as a niche sustainability issue rather than a foundational technology layer capable of reshaping whole economies. If Europe fails to adjust course soon, it risks sleepwalking into an old pattern: pioneering innovation, creating demand through regulation and then watching production, profits and geopolitical leverage migrate to China.

This paper argues that European policymakers should view biomanufacturing not simply as another industrial sector but as a strategic foundational technology layer. They should see China’s push for leadership in this field as a geopolitical challenge as much as an economic one. The EU needs policies and investments that amplify its significant advantages in research and innovation before they are eroded by China’s scale and industrial capacity. As with solar panels and batteries before it, Europe risks inventing the future only to surrender its strategic power—but this time with far greater consequences.

Biotechnology, biosolutions, biomanufacturing

The terminology surrounding the sector can be confusing. Biotechnology is the broadest catch-all description. In Europe, the term biosolutions is sometimes used to distinguish industrial applications of biotechnology from the pharmaceutical sector, although the boundary between the two is not always clear.

The distinction matters because the pharmaceutical sector follows a very different commercial logic. Biopharmaceutical companies develop low-volume and high-value products, such as specialised cancer treatment, where expensive R&D can be justified by potentially high returns—“consumers”, after all, are willing to pay steep prices for lifesaving or life-enhancing drugs.

By contrast, biosolutions often focus on replacing existing products (fertilisers or fuels). They create an alternative with environmental advantages (animal-free dairy) or inventing entirely new materials with specific qualities (spider-silk fabric) and wide industrial appeal. Unlike pharmaceuticals, these products must compete directly with established products or industries in low-margin markets often dominated by powerful incumbents.

China prefers the term biomanufacturing to describe the industrial applications of biotechnology. This reflects a focus on the process and a view that the technology is not simply the industrial application of biotechnology but the foundation of a new manufacturing model. As the world’s largest manufacturing power, China has already made it clear that it intends to dominate this next stage of industrial development. This policy brief adopts the same terminology to reflect that strategic perspective.

In the end, semantics matter less than the underlying shift. Whether described as biosolutions or biomanufacturing, the underlying transformation extends far beyond a collection of new products. It is a crucial layer of the emerging industrial economy, enabled by electrification and artificial intelligence.

The five pillars of biomanufacturing

Like the petrochemical industry before it, biomanufacturing at scale needs an industrial infrastructure.

Precision fermentation, one of the most promising techniques of the sector, uses genetically engineered microorganisms to produce specific target molecules. These organisms are cultivated in fermentation tanks and supplied with sugar-based feedstocks. The produced molecule is then extracted and purified. It could be a dairy protein made without a cow, a polymer with all the qualities of traditional plastic but none of the fossil-based input, or a protein that mimics spider silk, creating fibres strong enough to be used for body armour.

Disclaimer

The Views expressed in this article are those of the author and do not necessarily reflect those of CEMAS editorial team.